Maternal, fetal, neonatal and breastmilk flecainide concentration during maternal therapy and lactation: a case report

Abstract Background Mothers requiring the antiarrhythmic agent flecainide are often advised not to breastfeed, because of the lack of data concercing neonatal effects and flecainide plasma concentrations following maternal exposure as well as via lactation. This is the first report on combined mater...

Full description

Bibliographic Details
Main Authors: Johanna A. van der Zande, Jérôme M.J. Cornette, Jolien W. Roos-Hesselink, Robert B. Flint
Format: Article
Language:English
Published: BMC 2023-04-01
Series:International Breastfeeding Journal
Subjects:
Online Access:https://doi.org/10.1186/s13006-023-00559-z